Section Arrow
Quote
AXGN.NASDAQ
- Axogen
Quotes are at least 15-min delayed:2025/06/28 11:18 EDT
Last
 10.5
+0.03 (+0.29%)
Day High 
10.62 
Prev. Close
10.47 
1-M High
11.58 
Volume 
1.10M 
Bid
10.5
Ask
13
Day Low
10.2 
Open
10.47 
1-M Low
9.215 
Market Cap 
476.85M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 9.88 
20-SMA 10.34 
50-SMA 12.5 
52-W High 21 
52-W Low 7.09 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.16/0.73
Enterprise Value
543.56M
Balance Sheet
Book Value Per Share
2.31
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
187.34M
Operating Revenue Per Share
3.34
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed：2025/06/28 11:18 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.